The China Mail - Formerra to Supply Foster Medical Compounds in Europe

USD -
AED 3.67315
AFN 62.508602
ALL 82.901415
AMD 377.320103
ANG 1.790083
AOA 917.000446
ARS 1397.45603
AUD 1.43901
AWG 1.80225
AZN 1.700706
BAM 1.687977
BBD 2.01456
BDT 122.73608
BGN 1.709309
BHD 0.377588
BIF 2967.5
BMD 1
BND 1.279846
BOB 6.926967
BRL 5.284006
BSD 1.000203
BTN 93.723217
BWP 13.705842
BYN 2.961192
BYR 19600
BZD 2.011712
CAD 1.378275
CDF 2277.500338
CHF 0.791905
CLF 0.023254
CLP 918.179579
CNY 6.892698
CNH 6.90259
COP 3705.94
CRC 466.057627
CUC 1
CUP 26.5
CVE 95.375002
CZK 21.140432
DJF 177.720285
DKK 6.458295
DOP 59.874991
DZD 132.744974
EGP 52.575297
ERN 15
ETB 157.374952
EUR 0.864097
FJD 2.2267
FKP 0.74705
GBP 0.748095
GEL 2.714977
GGP 0.74705
GHS 10.905012
GIP 0.74705
GMD 73.000221
GNF 8780.00019
GTQ 7.659677
GYD 209.341164
HKD 7.82618
HNL 26.519884
HRK 6.514398
HTG 131.152069
HUF 338.600498
IDR 16919
ILS 3.12535
IMP 0.74705
INR 94.12285
IQD 1310
IRR 1315049.999853
ISK 124.289869
JEP 0.74705
JMD 157.845451
JOD 0.708962
JPY 159.145006
KES 129.505219
KGS 87.448496
KHR 4015.000082
KMF 425.000187
KPW 899.971148
KRW 1501.980286
KWD 0.30663
KYD 0.833571
KZT 482.866057
LAK 21550.000246
LBP 89549.999464
LKR 314.407654
LRD 183.602089
LSL 16.849649
LTL 2.95274
LVL 0.60489
LYD 6.395021
MAD 9.361979
MDL 17.4948
MGA 4164.999916
MKD 53.274154
MMK 2099.628947
MNT 3568.971376
MOP 8.061125
MRU 40.110041
MUR 49.241272
MVR 15.450211
MWK 1736.999739
MXN 17.821301
MYR 3.956501
MZN 63.899281
NAD 16.820108
NGN 1379.906022
NIO 36.720467
NOK 9.72285
NPR 149.95361
NZD 1.723707
OMR 0.384506
PAB 1.000203
PEN 3.473017
PGK 4.305501
PHP 60.074007
PKR 279.249903
PLN 3.69763
PYG 6526.476592
QAR 3.643996
RON 4.402503
RSD 101.500987
RUB 80.49933
RWF 1460
SAR 3.753711
SBD 8.051718
SCR 14.408321
SDG 600.99945
SEK 9.363065
SGD 1.280945
SHP 0.750259
SLE 24.550032
SLL 20969.510825
SOS 571.500489
SRD 37.340116
STD 20697.981008
STN 21.63
SVC 8.752314
SYP 110.977546
SZL 16.849782
THB 32.743003
TJS 9.597587
TMT 3.5
TND 2.904952
TOP 2.40776
TRY 44.34383
TTD 6.795811
TWD 31.96405
TZS 2569.999672
UAH 43.928935
UGX 3745.690083
UYU 40.762429
UZS 12205.000254
VES 456.504355
VND 26357
VUV 119.458227
WST 2.748874
XAF 566.134155
XAG 0.014408
XAU 0.000228
XCD 2.70255
XCG 1.802694
XDR 0.704159
XOF 568.499098
XPF 103.401522
YER 238.649518
ZAR 17.08035
ZMK 9001.198055
ZMW 18.929544
ZWL 321.999592
  • CMSC

    -0.0100

    22.87

    -0.04%

  • RBGPF

    -13.5000

    69

    -19.57%

  • NGG

    0.2700

    82.33

    +0.33%

  • RYCEF

    -0.4500

    15.6

    -2.88%

  • AZN

    1.7100

    185.78

    +0.92%

  • GSK

    0.9600

    52.95

    +1.81%

  • BCE

    0.0700

    25.83

    +0.27%

  • BP

    1.2200

    44.79

    +2.72%

  • RIO

    0.9300

    86.77

    +1.07%

  • BTI

    -0.1600

    57.76

    -0.28%

  • BCC

    1.6900

    73.57

    +2.3%

  • CMSD

    -0.1100

    22.63

    -0.49%

  • RELX

    -1.3500

    32.46

    -4.16%

  • JRI

    0.1800

    11.86

    +1.52%

  • VOD

    0.1800

    14.66

    +1.23%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

O.Yip--ThChM